- Home
- ADXN vs LCFY Comparison
ADXN vs LCFY Comparison
Compare ADXN & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- LCFY
- Stock Information
- Founded
- ADXN 2002
- LCFY 2009
- Country
- ADXN Switzerland
- LCFY Australia
- Employees
- ADXN N/A
- LCFY N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- LCFY
- Sector
- ADXN Health Care
- LCFY
- Exchange
- ADXN Nasdaq
- LCFY Nasdaq
- Market Cap
- ADXN 10.1M
- LCFY 5.9M
- IPO Year
- ADXN N/A
- LCFY 2022
- Fundamental
- Price
- ADXN $9.00
- LCFY $4.35
- Analyst Decision
- ADXN Strong Buy
- LCFY
- Analyst Count
- ADXN 1
- LCFY 0
- Target Price
- ADXN $30.00
- LCFY N/A
- AVG Volume (30 Days)
- ADXN 14.4K
- LCFY 5.0M
- Earning Date
- ADXN 08-11-2025
- LCFY 07-22-2025
- Dividend Yield
- ADXN N/A
- LCFY N/A
- EPS Growth
- ADXN N/A
- LCFY N/A
- EPS
- ADXN 0.10
- LCFY N/A
- Revenue
- ADXN $278,508.00
- LCFY $2,668,385.00
- Revenue This Year
- ADXN $86.57
- LCFY N/A
- Revenue Next Year
- ADXN N/A
- LCFY N/A
- P/E Ratio
- ADXN $0.78
- LCFY N/A
- Revenue Growth
- ADXN N/A
- LCFY N/A
- 52 Week Low
- ADXN $6.51
- LCFY $2.51
- 52 Week High
- ADXN $13.27
- LCFY $13.98
- Technical
- Relative Strength Index (RSI)
- ADXN 49.41
- LCFY 49.37
- Support Level
- ADXN $8.78
- LCFY $4.28
- Resistance Level
- ADXN $9.89
- LCFY $5.40
- Average True Range (ATR)
- ADXN 0.67
- LCFY 1.21
- MACD
- ADXN -0.03
- LCFY -0.03
- Stochastic Oscillator
- ADXN 43.01
- LCFY 16.04
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.